Intelligence · Clinical Development
Pipeline search results
Programs matching “glatiramer acetate” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 14 pipeline programs matching "glatiramer acetate" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Glatiramer Acetate
Teva Pharma GmbH
Optic Neuritis
1 trial -
Glatiramer Acetate (DB)
Teva Pharma GmbH
Multiple Sclerosis
1 trial -
Glatiramer Acetate (GA) 40 mg
Teva Pharma GmbH
Relapsing Remitting Multiple Sclerosis
1 trial -
Glatiramer Acetate 20 mg/0.5 mL
Teva Pharma GmbH
Multiple Sclerosis
1 trial -
Glatiramer acetate (GA)
Teva Pharma GmbH
Relapsing Remitting Multiple Sclerosis
1 trial -
40 mg glatiramer acetate
Teva Pharma GmbH
Amyotrophic Lateral Sclerosis
1 trial -
Glatiramer Acetate, N-Acetylcysteine
Teva Pharma GmbH
Relapse Remitting Multiple Sclerosis
1 trial -
glatiramer acetate
Teva Pharma GmbH
Crohns Disease
1 trial -
glatiramer acetate 20 mg
Teva Pharma GmbH
Relapsing Remitting Multiple Sclerosis
1 trial -
glatiramer acetate 20 mg
Teva Pharma GmbH
Relapse-Remitting Multiple Sclerosis
1 trial -
glatiramer acetate with minocycline
Teva Pharma GmbH
Relapse Remitting Multiple Sclerosis
1 trial -
Glatiramer Acetate
Teva Pharma GmbH
Relapsing Remitting Multiple Sclerosis
5 trials -
glatiramer acetate
Teva Pharma GmbH
Multiple Sclerosis
2 trials -
glatiramer acetate injection with oral cetirizine hydrochloride
Teva Pharma GmbH
Multiple Sclerosis
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.